1. LUDWIG H, BOCCADORO M, MOREAU P, SAN-MIGUEL J, CAVO M, PAWLYN C, ZWEEGMAN S, FACON T, DRIESSEN C, HAJEK R, DIMOPOULOS M A, GAY F, AVET-LOISEAU H, TERPOS E, ZOJER N, MOHTY M, MATEOS M V, EINSELE H, DELFORGE M, CAERS J, WEISEL K, JACKSON G, GARDERET L, ENGELHARDT M, VAN DE DONK N, LELEU X, GOLDSCHMIDT H, BEKSAC M, NIJHOF I, ABILDGAARD N, BRINGHEN S, SONNEVELD P. Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network. Leukemia, 2021, 35(1): 31–44.
2. NEUSE C J, LOMAS O C, SCHLIEMANN C, SHEN Y J, MANIER S, BUSTOROS M, GHOBRIAL I M. Genome instability in multiple myeloma. Leukemia, 2020, 34(11): 2887–2897.
3. PETRUCCI M T, VOZELLA F. The anti-CD38 antibody therapy in multiple myeloma. Cells, 2019, 8(12): 1629.
4. XIAO H Y, HU D J, WANG Y M, GUO Z J. Clinical observation of Huoxue Zhuyu decoction combined with chemotherapy in treatment of multiple myeloma and its effect on immune function. Zhonghua Zhongyiyao Xuekan, 2020, 38(6): 160–164.
5. HE Y L. Study on the Effect of Spleen and Kidney Strengthening Combined with TCD on the Quality of Life of Patients with Multiple Myeloma with Kidney Damage and Spleen and Kidney Deficiency Syndrome. Chengdu: Master Thesis of Chengdu University of Traditional Chinese Medicine, 2019.